Constellation Brands, Inc. (STZ) Financial Statements & Historical Data

Constellation Brands, Inc. (STZ) — Price $138.13 (closing price, November 3, 2026) — Consumer Defensive — Beverages - Alcoholic — NYSE

Latest reported results:

Detailed financial statements for Constellation Brands, Inc. (STZ): income statement, balance sheet and cash-flow summary. Track margins, debt, liquidity and profitability trends year over year: ten fiscal years free and up to 20 with Premium.

Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. The company offers beer under the Corona Extra, Corona Familiar, Corona Hard Seltzer, Corona Light, Corona Non-Alcoholic, Corona Premier, Corona Refresca, Modelo Especial, Modelo Chelada, Modelo Negra, Modelo Oro, Victoria, Vicky Chamoy, and Pacifico brands.

Analysis Summary

Constellation Brands, Inc. reported revenue of $9.14B in the most recent fiscal year, growing at a 5-year CAGR of 1.2%. Net income reached $1.69B, with a -3.3% 5-year CAGR.

Trailing-twelve-month margins: gross margin 52.7%, operating margin 30.9%, net margin 20.9%. Free cash flow grew at -1.6% CAGR over 5 years.

At $138.13 (closing price, November 3, 2026), STZ trades at a P/E of 12.39 and an ROE of 23.58%. Market capitalisation stands at $23.4B, placing it among large-cap names.

Balance sheet quality for STZ: debt-to-equity ratio of 1.20, current ratio of 1.00 over the last 12 months, net debt of $11.10B at the end of the last fiscal year. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.

Cash flow quality is strong: free cash flow of $1.79B represents 106% conversion of reported net income. High conversion (above 90%) suggests earnings translate cleanly into cash; lower conversion may indicate working capital tightness or accounting timing differences.

Income Statement (10y)

Year2017201820192020202120222023202420252026
Revenue$7.33B$7.58B$8.12B$8.34B$8.61B$8.82B$9.45B$9.96B$10.21B$9.14B
Cost of Revenue$3.79B$3.76B$4.01B$4.02B$4.14B$4.22B$4.64B$5.05B$5.01B$4.43B
Gross Profit$3.54B$3.82B$4.10B$4.32B$4.47B$4.60B$4.81B$4.91B$5.20B$4.71B
Research & Development0000000000
Selling, General & Admin$1.29B$1.38B$1.45B$1.55B$1.61B$1.70B$1.82B$1.78B$1.58B$1.85B
Operating Expenses$1.29B$1.53B$1.45B$1.55B$1.61B$1.70B$1.82B$1.78B$1.58B$1.85B
Operating Income$2.25B$2.28B$2.65B$2.77B$2.86B$2.90B$2.99B$3.13B$3.62B$2.86B
EBITDA$2.66B$2.97B$4.89B-$190.0M$3.22B$1.00B$1.17B$3.08B$781.3M$3.15B
Interest Expense$331.1M$336.5M$414.1M$428.7M$382.8M$352.2M$397.8M$433.8M$411.4M$352.6M
Pre-tax Income$2.09B$2.34B$4.14B-$945.2M$2.54B$310.4M$383.6M$2.22B-$82.8M$2.38B
Income Tax$554.2M$22.7M$685.9M-$966.6M$511.1M$309.4M$422.1M$456.6M-$51.7M$621.0M
Net Income$1.54B$2.30B$3.44B-$11.8M$2.00B-$40.4M-$71.0M$1.73B-$81.4M$1.69B
EPS$7.79$11.55$18.03-$0.06$10.42-$0.21-$0.37$9.42-$0.45$9.62
EPS (Diluted)$7.52$11.55$17.57-$0.06$10.23-$0.21-$0.37$9.39-$0.45$9.61
Shares Outstanding (Diluted)204.1 M200.7 M195.5 M189.3 M195.3 M190.4 M192.5 M184.0 M181.5 M175.6 M

Income Statement (Quarterly)

Year2025-Q42026-Q12026-Q22026-Q3
Revenue$2.22B$1.92B$2.43B$2.63B
Gross Profit$1.18B$951.7M$1.32B$1.39B
Operating Income$692.0M$499.3M$845.3M$805.0M
EBITDA$817.9M$546.2M$971.7M$909.6M
Net Income$502.8M$201.8M$653.8M$565.8M
EPS$2.88$1.16$3.80$3.32
EPS (Diluted)$2.88$1.16$3.79$3.32

Balance Sheet (10y)

Year2017201820192020202120222023202420252026
Cash & Equivalents$177.4M$90.3M$93.6M$81.4M$460.6M$199.4M$133.5M$152.4M$68.1M$102.4M
Short-term Investments0000000000
Receivables$837.4M$1.11B$1.27B$1.22B$1.09B$1.12B$1.08B$1.08B$992.7M$947.3M
Inventory$1.96B$2.08B$2.13B$1.37B$1.29B$1.57B$1.90B$2.08B$1.44B$1.43B
Total Current Assets$3.23B$3.47B$3.68B$3.48B$3.04B$3.33B$3.50B$3.73B$3.72B$2.91B
Property, Plant & Equipment$3.93B$4.79B$5.27B$5.81B$6.30B$6.54B$6.87B$8.67B$7.96B$8.52B
Goodwill$7.92B$8.08B$8.09B$7.76B$7.79B$7.86B$7.93B$7.98B$5.13B$5.23B
Intangible Assets$3.38B$3.30B$3.20B$2.72B$2.73B$2.76B$2.73B$2.73B$2.53B$2.53B
Total Assets$18.60B$20.54B$29.23B$27.32B$27.10B$25.86B$24.66B$25.69B$21.65B$21.90B
Accounts Payable$559.8M$592.2M$616.7M$557.6M$460.0M$899.2M$941.5M$1.11B$939.8M$960.2M
Short-term Debt$1.52B$769.1M$1.86B$973.8M$29.2M$928.3M$1.17B$1.20B$2.21B$875.6M
Total Current Liabilities$2.70B$1.94B$3.16B$2.31B$1.27B$2.70B$2.97B$3.14B$4.04B$2.69B
Long-term Debt$7.72B$9.42B$11.76B$11.21B$10.41B$9.49B$11.29B$10.68B$9.29B$9.69B
Total Liabilities$11.72B$12.48B$16.39B$14.85B$13.18B$13.81B$15.93B$15.63B$14.52B$13.51B
Retained Earnings$7.31B$9.16B$14.28B$13.70B$15.12B$14.51B$12.34B$13.42B$12.60B$13.57B
Total Equity$6.89B$7.98B$12.55B$12.13B$13.60B$11.73B$8.41B$9.74B$6.88B$8.08B
Total Debt$9.24B$10.19B$13.62B$12.74B$10.98B$10.95B$12.96B$12.56B$12.11B$11.20B
Net Debt$9.06B$10.10B$13.52B$12.66B$10.52B$10.75B$12.83B$12.41B$12.05B$11.10B
Working Capital$532.4M$1.53B$520.2M$1.17B$1.78B$630.9M$527.8M$587.8M-$318.8M$216.5M

Balance Sheet (Quarterly)

Year2025-Q42026-Q12026-Q22026-Q3
Cash & Equivalents$152.4M$102.4M$96.6M$98.5M
Total Assets$21.68B$21.90B$22.11B$22.06B
Total Liabilities$13.68B$13.51B$13.56B$13.18B
Total Equity$7.71B$8.08B$8.26B$8.59B
Total Debt$10.66B$11.20B$10.53B$10.32B

Cash Flow (10y)

Year2017201820192020202120222023202420252026
Net Income$1.53B$2.32B$3.46B$21.4M$2.03B$1.0M-$38.5M$1.77B-$31.1M$1.69B
Depreciation & Amortization$237.5M$293.8M$333.1M$326.5M$299.1M$342.4M$383.8M$427.9M$445.7M$420.0M
Stock-based Compensation$56.1M$60.9M$64.1M$60.4M$63.0M$44.9M$68.5M$63.6M$72.2M0
Change in Working Capital-$23.5M-$323.4M-$237.5M-$83.7M$148.3M-$185.6M-$274.5M-$287.8M-$134.2M-$357.8M
Operating Cash Flow$1.70B$1.93B$2.25B$2.55B$2.81B$2.71B$2.76B$2.78B$3.15B$2.67B
Capital Expenditure-$907.4M-$1.06B-$886.3M-$726.5M-$864.6M-$1.03B-$1.04B-$1.27B-$1.21B-$875.0M
Acquisitions-$535.7M-$366.0M-$4.13B$185.3M$757.2M-$85.5M$28.8M$19.8M$286.0M$909.5M
Stock Repurchased-$1.12B-$1.04B-$504.3M-$50.0M0-$1.39B-$3.20B-$249.7M-$1.12B-$924.1M
Dividends Paid-$315.1M-$400.1M-$557.7M-$569.2M-$575.0M-$573.0M-$587.7M-$653.8M-$731.8M-$715.7M
Free Cash Flow$788.6M$873.8M$1.36B$1.82B$1.94B$1.68B$1.72B$1.51B$1.94B$1.79B

Cash Flow (Quarterly)

Year2025-Q42026-Q12026-Q22026-Q3
Operating Cash Flow$616.9M$562.8M$661.8M$816.8M
Capital Expenditure-$246.0M-$218.9M-$177.2M-$176.9M
Free Cash Flow$370.9M$343.9M$484.6M$639.9M
Dividends Paid-$177.7M-$176.9M-$178.7M-$175.1M
Stock-based Compensation-$29.0M0$15.0M$19.9M

Growth & Margins (10y)

Year2017201820192020202120222023202420252026
Revenue Growth (YoY)+3.4%+7.0%+2.8%+3.2%+2.4%+7.2%+5.4%+2.5%-10.5%
Net Income Growth (YoY)+50.0%+49.2%-100.3%+17,032.2%-102.0%-75.7%+2,533.0%-104.7%+2,172.1%
EPS Growth (YoY)+48.3%+56.1%-100.3%+16,825.5%-102.0%-76.2%+2,645.9%-104.8%+2,237.8%
Shares Change (YoY)-1.6%-2.6%-3.2%+3.2%-2.5%+1.1%-4.5%-1.3%-3.3%
FCF Growth (YoY)+10.8%+55.6%+34.2%+6.4%-13.6%+2.6%-12.2%+28.3%-7.4%
Gross Margin48.3%50.4%50.5%51.8%51.9%52.1%50.9%49.3%51.0%51.6%
Operating Margin30.7%30.1%32.7%33.2%33.2%32.9%31.6%31.5%35.5%31.3%
EBITDA Margin36.3%39.2%60.3%-2.3%37.4%11.4%12.3%31.0%7.7%34.5%
Net Margin20.9%30.4%42.3%-0.1%23.2%-0.5%-0.8%17.3%-0.8%18.5%
FCF Margin10.8%11.5%16.8%21.9%22.5%19.0%18.2%15.2%19.0%19.6%
Effective Tax Rate26.5%1.0%16.5%102.3%20.1%99.7%110.0%20.6%62.4%26.1%

Per-Share Data (10y)

Year2017201820192020202120222023202420252026
FCF Per Share$3.86$4.35$6.96$9.64$9.94$8.82$8.94$8.21$10.68$10.22
Dividends Per Share$1.54$1.99$2.85$3.01$2.94$3.01$3.05$3.55$4.03$4.08
Shares Outstanding (Basic)199.3 M194.8 M190.6 M189.3 M191.7 M190.4 M192.5 M183.3 M181.5 M175.4 M

What to look at in Consumer Defensive companies

Profitability

Return on Equity23.58%
Return on Invested Capital11.32%
Return on Assets8.72%
Gross Margin52.65%
Operating Margin30.86%
Net Margin20.90%

Financial Health

Debt / Equity1.20
Current Ratio1.00
Piotroski F-Score7
Altman Z-Score2.96

Key Ratios (10y)

Year2017201820192020202120222023202420252026
P/E20.3918.669.38-2,766.9320.90-1,026.76-604.5926.38-390.0016.41
P/B4.595.262.572.693.073.505.124.684.633.43
P/S4.325.543.973.914.854.654.564.573.123.03
Gross Margin48.3%50.4%50.5%51.8%51.9%52.1%50.9%49.3%51.0%51.6%
Operating Margin30.7%30.1%32.7%33.2%33.2%32.9%31.6%31.5%35.5%31.3%
Net Margin20.9%30.4%42.3%-0.1%23.2%-0.5%-0.8%17.3%-0.8%18.5%

Related companies: BUD · ABEV · DEO · BF-B · TAP · SAM

Explore sector: Consumer Defensive · Beverages - Alcoholic

More sections of STZ: Overview · Valuation · Statistics · Estimates · Technical · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks